Literature DB >> 7373616

Clinical significance of synovial fluid total hemolytic complement activity.

H J Kim, D J McCarty, F Kozin, S Koethe.   

Abstract

Total hemolytic complement (CH50) was measured in 174 synovial fluids (SF) to determine its diagnostic and and prognostic value. SF CH50 was reduced relative to serum CH50 in 61% of patients with rheumatoid arthritis and 60% of patients with crystal-induced arthritis. There was no correlation of SF CH50 levels with disease duration, SF leukocyte count, presence of IgM rheumatoid factor, or radiologic evidence of erosions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373616

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  C1 inactivator-C1s complexes in inflammatory joint disease.

Authors:  R D Inman; P C Harpel
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

2.  An analysis of the levels of complement components in the synovial fluid in rheumatic diseases.

Authors:  A J Swaak; A Van Rooyen; O Planten; H Han; O Hattink; E Hack
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

3.  Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy.

Authors:  M Doherty; N Richards; J Hornby; R Powell
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.